LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · IEX Real-Time Price · USD
+1.27 (1.61%)
May 22, 2024, 4:00 PM EDT - Market closed

Company Description

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide.

It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.

The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries.

In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin.

Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures.

It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001.

LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

LeMaitre Vascular, Inc.
LeMaitre Vascular logo
Country United States
Founded 1983
IPO Date Oct 19, 2006
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 630
CEO George W. LeMaitre

Contact Details

63 Second Avenue
Burlington, Massachusetts 01803
United States
Phone 781-221-2266
Website lemaitre.com

Stock Details

Ticker Symbol LMAT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001158895
CUSIP Number 525558201
ISIN Number US5255582018
SIC Code 3841

Key Executives

Name Position
George W. LeMaitre Chairman and Chief Executive Officer
David B. Roberts President and Director
Joseph P. Pellegrino Jr. Chief Financial Officer, Treasurer, Secretary and Director
Trent G. Kamke Senior Vice President of Operations
Dr. George D. LeMaitre Founder and Chairman of Scientific Advisory Board
David C. Hissong General Counsel
Kimberly L. Cieslak Vice President of Marketing
Daniel J. Mumford Director of Human Resources
Ryan H. Connelly Senior Vice President of Advanced Manufacturing Engineering
Andrew Hodgkinson Senior Vice President of Clinical, Regulatory and Quality Affairs

Latest SEC Filings

Date Type Title
May 16, 2024 144 Filing
May 10, 2024 10-Q Quarterly Report
May 6, 2024 144 Filing
May 6, 2024 144 Filing
May 6, 2024 144 Filing
May 2, 2024 8-K Current Report
Apr 16, 2024 ARS Filing
Apr 16, 2024 DEF 14A Other definitive proxy statements
Mar 8, 2024 144 Filing
Mar 5, 2024 144 Filing